Geneservice’s Commitment to Quality is Underlined by ISO 9001:2000 Certification
News Apr 21, 2006
Geneservice Ltd has announced it has received the International Standards Organisation’s (ISO) 9001:2000 certification for the provision of functional genomic products and contract research to academic and commercial research communities worldwide.
This follows external validation by Lloyds Register of Quality Assurance (LRQA) a UKAS accredited quality certification body.
The achievement of ISO9001:2000 approval reinforces Geneservice’s continued commitment to identify and meet the needs and expectations of its customers and achieve, maintain and improve overall operational performance and capabilities.
Commenting Tom Weaver, CEO said, "This certification further demonstrates Geneservice’s commitment to the highest levels of product and service quality."
"The staff’s enthusiasm and self motivation was shown clearly by their commitment to the development and application of a Quality Management System at Geneservice."
As genome editing technologies advance toward clinical therapies, they are raising hopes of a completely new way to treat disease. However, challenges need to be addressed before potential treatments can be widely used in patients. To tackle these challenges, the National Institutes of Health has launched the Somatic Cell Genome Editing program, which has awarded multiple grants including more than $3.6 million to assess the safety of genome editing in human cells and tissues.